Innovent Biologics, Inc. (IVBXF) Stock Overview
Explore Innovent Biologics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Innovent Biologics, Inc. (IVBXF)
Key Financials
Key Financials
Market Cap
17B
P/E Ratio
70.50
EPS (TTM)
$0.07
ROE
0.05%
IVBXF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Innovent Biologics, Inc. (IVBXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 45.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.42.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 70.50 and a market capitalization of 17B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.